Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1969 1
1970 1
1971 2
1973 2
1974 1
1975 4
1976 3
1977 3
1978 1
1980 1
1981 3
1983 4
1984 1
1986 1
1989 1
1994 1
1996 2
1997 1
1999 1
2000 1
2001 1
2003 1
2009 1
2012 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy of preterm labor.
Souney PF, Kaul AF, Osathanondh R. Souney PF, et al. Clin Pharm. 1983 Jan-Feb;2(1):29-44. Clin Pharm. 1983. PMID: 6136361 Review.
For both short-term and long-term tocolysis, beta 2-sympathomimetic agents (betamimetics) can be used. These drugs, which include isoxsuprine, ritodrine, terbutaline, albuterol, nylidrin, fenoterol, metaproterenol, and hexoprenaline, are believed to affect intracellular ca …
For both short-term and long-term tocolysis, beta 2-sympathomimetic agents (betamimetics) can be used. These drugs, which include isoxsup …
The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses.
Ingle-Fehr JE, Baxter GM. Ingle-Fehr JE, et al. Vet Surg. 1999 May-Jun;28(3):154-60. doi: 10.1053/jvet.1999.0154. Vet Surg. 1999. PMID: 10338160 Clinical Trial.
A mild but insignificant increase in LP was identified after acetylpromazine treatment. CONCLUSION: Neither isoxsuprine nor pentoxifylline increased blood flow to the digit or dorsal laminae in healthy horses. ...Based on the results of this study acetylpromazine potential …
A mild but insignificant increase in LP was identified after acetylpromazine treatment. CONCLUSION: Neither isoxsuprine nor pentoxify …
Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
Bhadage CJ, Umarji HR, Shah K, Välimaa H. Bhadage CJ, et al. Clin Oral Investig. 2013 Jun;17(5):1375-82. doi: 10.1007/s00784-012-0824-z. Epub 2012 Aug 15. Clin Oral Investig. 2013. PMID: 22893038 Clinical Trial.
OBJECTIVES: The aim of the study was to compare the effectiveness of vasodilator isoxsuprine to dexamethasone with hyaluronidase injections and physiotherapy in the treatment of oral submucous fibrosis. ...CLINICAL RELEVANCE: Oral isoxsuprine can be considered as a …
OBJECTIVES: The aim of the study was to compare the effectiveness of vasodilator isoxsuprine to dexamethasone with hyaluronidase inje …
Pharmacokinetics of isoxsuprine hydrochloride administered orally and intramuscularly to female healthy volunteers.
Marzo A, Zava D, Coa K, Dal Bo L, Ismaili S, Tavazzi S, Cantoni V. Marzo A, et al. Arzneimittelforschung. 2009;59(9):455-60. doi: 10.1055/s-0031-1296425. Arzneimittelforschung. 2009. PMID: 19856793 Clinical Trial.
Isoxsuprine (1-(4-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-1-propanol, CAS 395-28-8) is a peripheral vasodilator that also stimulates beta-adrenergic receptors. ...The distribution volume of the free drug proved to be 2.5 times higher than that of total isoxsupri …
Isoxsuprine (1-(4-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-1-propanol, CAS 395-28-8) is a peripheral vasodilator that also sti …
Cerebral vasodilators (second of two parts).
Cook P, James I. Cook P, et al. N Engl J Med. 1981 Dec 24;305(26):1560-4. doi: 10.1056/NEJM198112243052604. N Engl J Med. 1981. PMID: 7031468 Review. No abstract available.
Treatment of imminent premature labour.
Castrén O, Gummerus M, Saarikoski S. Castrén O, et al. Acta Obstet Gynecol Scand. 1975;54(2):95-100. doi: 10.3109/00016347509156739. Acta Obstet Gynecol Scand. 1975. PMID: 1094787 Clinical Trial.
Therapeutic effects of high-dose isoxsuprine in the management of mixed-type impotence.
Safarinejad MR. Safarinejad MR. Urology. 2001 Jul;58(1):95-7. doi: 10.1016/s0090-4295(01)01084-6. Urology. 2001. PMID: 11445487 Clinical Trial.
Positive clinical results (complete and partial responses) were obtained in 6 men (16.6%) at the end of the isoxsuprine phase and in 7 men (19.4%) after the placebo period. The statistical analysis disclosed no significant difference when isoxsuprine was compared wi …
Positive clinical results (complete and partial responses) were obtained in 6 men (16.6%) at the end of the isoxsuprine phase and in …
Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.
Wesseling H, den Heeten A, Wouda AA. Wesseling H, et al. Eur J Clin Pharmacol. 1981;20(5):329-33. doi: 10.1007/BF00615400. Eur J Clin Pharmacol. 1981. PMID: 7026260 Clinical Trial.
Oral and sublingual isoxsuprine 20 mg were compared with placebo in double blind randomised cross over trial in 7 patients with Raynaud's phenomenon. Skin thermography, plethysmography of the finger tips and direct temperature measurements showed that sublingual isoxsup …
Oral and sublingual isoxsuprine 20 mg were compared with placebo in double blind randomised cross over trial in 7 patients with Rayna …
A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour.
Raymajhi R, Pratap K. Raymajhi R, et al. Kathmandu Univ Med J (KUMJ). 2003 Apr-Jun;1(2):85-90. Kathmandu Univ Med J (KUMJ). 2003. PMID: 16388203 Clinical Trial.
This study compares in a prospective and randomised design the efficacy and safety of the calcium antagonist Nifedipine with the beta mimetic Isoxsuprine. 81.25% of patients receiving Nifedipine and 70% of those receiving Isoxsuprine achieved successful tocolysis. . …
This study compares in a prospective and randomised design the efficacy and safety of the calcium antagonist Nifedipine with the beta mimeti …
Studies on isoxsuprine hydrochloride for the treatment of navicular disease.
Rose RJ, Allen JR, Hodgson DR, Kohnke JR. Rose RJ, et al. Equine Vet J. 1983 Jul;15(3):238-43. doi: 10.1111/j.2042-3306.1983.tb01778.x. Equine Vet J. 1983. PMID: 6349984 Clinical Trial.
A peripheral vasodilating agent, isoxsuprine hydrochloride, administered as an oral paste, was evaluated to determine its efficacy for the treatment of navicular disease. ...In a controlled randomised double blind clinical trial, 16 horses with navicular disease were assig …
A peripheral vasodilating agent, isoxsuprine hydrochloride, administered as an oral paste, was evaluated to determine its efficacy fo …
41 results